• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Vivus

Pharma

ICER put four recent obesity meds under a microscope

Novo Nordisk’s weight loss newcomer Wegovy may not be the thriftiest obesity med on the market, but its efficacy and safety look good, ICER says.
Fraiser Kansteiner Jul 13, 2022 9:30am

FDA rebukes Metuchen for 'misleading' Stendra ads

Aug 29, 2019 4:03pm

FDA's promo police ding Vivus for misleading Qsymia webpage

Jun 6, 2019 12:43pm

Vivus, diving into CF, backs stadium step-climbing fundraiser

Sep 27, 2018 11:05am

Novo preps big obesity push, undeterred by its rivals' fates

Nov 21, 2017 11:57am

Sanofi wipes its hands of Vivus ED med Stendra

Mar 29, 2017 9:55am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy